Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
Eversense® NOW is a mobile App that allows the Eversense® users to share their data and information with friends and family. The Eversense® NOW user will be able to monitor the CGM glucose data of up to 10 Eversense® CGM users.
Note: The Eversense® CGM user has the ability to add/remove friends and family from Eversense NOW access to their data at any time.
The Eversense® My Circle refers to the group of people you invite (up to 5 people) to remotely view your Eversense® CGM data. To join the Circle, those you invite must accept the invitation they receive from you. They will need to download and install the Eversense® NOW Mobile App in order to see your glucose data.
The Weekly Modal Summary report shows your last seven days of glucose readings summarized in a
24-hour line graph format to help find patterns during the day.
- The blue line is the average of the last seven days of your readings in an hour time block.
- The red bars show the highest and lowest actual readings in the same hour time block.
- The red horizontal dotted lines are your pre-set High and Low Glucose Alert levels.
- The green horizontal dotted lines are your pre-set High and Low Glucose Target levels.
This report also provides summary statistics (average readings, standard deviation of readings), glucose target performance (percent within, above and below glucose target levels), and glucose reading highs and lows (percent of readings that fall within the low and high glucose target levels).
The information is shown based on mealtime slots.
Our pre-qualification form will ask you a few questions about your diabetes type, therapy and your current insurance provider - this will allow us to tell you what your insurance may cover for Eversense. Our Eversense Expert will then get in touch with you to confirm your details and submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense 365 CGM.
The Eversense® E3 Smart Transmitter is a removable transmitter worn externally over the sensor. It wirelessly powers the sensor and collects glucose data via Near-Field Communication (NFC). It wirelessly sends glucose data (via Bluetooth) to the Eversense® Mobile App. It has a rechargeable battery and is warranted for one year.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1